Demand for medical marijuana in Germany is surging, substantiating the thesis of Canadian corporations positioning themselves to satisfy a provide shortfall there.
A complete of 13,000 sufferers had utilized for medical marijuana reimbursements from three giant medical insurance corporations by the top of 2017, Rheinische Post reported.
Only about 1,000 individuals had permission to make use of the drug in March.
The three insurance coverage companies – Allgemeine Ortskrankenkasse, Barmer and Techniker Krankenkasse – informed the newspaper they authorised MMJ purposes for about two-thirds of the candidates.
Failing to obtain insurance coverage protection leaves sufferers on the hook for the price of the prescribed drugs.
The newspaper estimated these prices ranged from 140 to 1,800 euros ($160 to $2,100) per 30 days.
Germany turned the most important federally authorized medical marijuana market in the world in 2017, however the market shall be served by imports till its home manufacturing is able to assembly native demand.
Every German citizen is mandated to have well being protection by means of a personal firm, and a few insurance coverage companies supply MMJ in their plans — making medical hashish accessible to the nation’s 70 million insured individuals.
Canadian corporations with their eyes set on the Germany medical marijuana market embrace Aurora, Tilray, Cronos Group, Canopy Growth, Maricann, ABcann, CanniMed, Nuuvera and MedReleaf.
To enroll for our weekly Canada marijuana enterprise publication, click on right here.